Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 1141 AL 1155

Predicting long-term progression of Alzheimer's disease using a multimodal deep learning model incorporating interaction effects

Wang Y, Gao R, Wei T, Johnston L, Yuan X, Zhang Y, Yu Z; Alzheimer’s Disease Neuroimaging Initiative.

J Transl Med. 2024 Mar 11;22(1):265. doi: 10.1186/s12967-024-05025-w.

Anosognosia in Alzheimer's Pathology: Validation of a New Measure

Terry C, Lecci L.

Arch Clin Neuropsychol. 2024 Aug 24;39(6):669-682. doi: 10.1093/arclin/acae020.

Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease

Balakrishnan R, Jannat K, Choi DK.

Redox Biol. 2024 May;71:103105. doi: 10.1016/j.redox.2024.103105. Epub 2024 Mar 4.

Recent Aspects of Periodontitis and Alzheimer's Disease-A Narrative Review

Cichońska D, Mazuś M, Kusiak A.

Int J Mol Sci. 2024 Feb 23;25(5):2612. doi: 10.3390/ijms25052612.

Exploring the Genetic Landscape of Mild Behavioral Impairment as an Early Marker of Cognitive Decline: An Updated Review Focusing on Alzheimer's Disease

Angelopoulou E, Koros C, Hatzimanolis A, Stefanis L, Scarmeas N, Papageorgiou SG.

Int J Mol Sci. 2024 Feb 24;25(5):2645. doi: 10.3390/ijms25052645.

Agmatine as a novel intervention for Alzheimer's disease: Pathological insights and cognitive benefits

Katariya RA, Sammeta SS, Kale MB, Kotagale NR, Umekar MJ, Taksande BG.

Ageing Res Rev. 2024 Apr;96:102269. doi: 10.1016/j.arr.2024.102269. Epub 2024 Mar 11.

Alzheimer's drugs, APPlication for Down syndrome?

Sokol DK, Lahiri DK.

Ageing Res Rev. 2024 Apr;96:102281. doi: 10.1016/j.arr.2024.102281. Epub 2024 Mar 19.

Shared and differing functional connectivity abnormalities of the default mode network in mild cognitive impairment and Alzheimer's disease

Wang Y, Li Q, Yao L, He N, Tang Y, Chen L, Long F, Chen Y, Kemp GJ, Lui S, Li F.

Cereb Cortex. 2024 Mar 1;34(3):bhae094. doi: 10.1093/cercor/bhae094.

Viral Infections, Are They a Trigger and Risk Factor of Alzheimer's Disease?

Rippee-Brooks MD, Wu W, Dong J, Pappolla M, Fang X, Bao X.

Pathogens. 2024 Mar 8;13(3):240. doi: 10.3390/pathogens13030240.

Upsetting the Balance: How Modifiable Risk Factors Contribute to the Progression of Alzheimer's Disease

Carroll CM, Benca RM.

Biomolecules. 2024 Feb 24;14(3):274. doi: 10.3390/biom14030274.

Formulating Treatment to Cure Alzheimer's Dementia: Approach #2

Fessel J.

Int J Mol Sci. 2024 Mar 20;25(6):3524. doi: 10.3390/ijms25063524.

The Interplay between Gut Microbiota and Cognitive Functioning in the Healthy Aging Population: A Systematic Review

Kossowska M, Olejniczak S, Karbowiak M, Mosiej W, Zielińska D, Brzezicka A.

Nutrients. 2024 Mar 15;16(6):852. doi: 10.3390/nu16060852.

Minimal clinically important difference in Alzheimer's disease: Rapid review

Muir RT, Hill MD, Black SE, Smith EE.

Alzheimers Dement. 2024 May;20(5):3352-3363. doi: 10.1002/alz.13770. Epub 2024 Apr 1.

Comparison of Enlarged Perivascular Spaces in Early-Onset and Late-Onset Alzheimer Disease-related Cognitive Impairment: A Single Clinic-based Study in South Korea

Jung NY, Je Y, Ham HG, Park YH, Kim TY, Go MS, Lee HI, Kim DE, Lee MJ, Seo SW, Kim EJ.

Alzheimer Dis Assoc Disord. 2024 Apr-Jun 01;38(2):201-204. doi: 10.1097/WAD.0000000000000614. Epub 2024 Apr 2.

Profiling lecanemab as a treatment option for Alzheimer's disease

Schiller ER, Silverglate BD, Grossberg GT.

Expert Rev Neurother. 2024 May;24(5):433-441. doi: 10.1080/14737175.2024.2333970. Epub 2024 Apr 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias